Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fahim Abbasi

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
The American Journal of Cardiology|January 12, 2005
Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemiaCindy Lamendola, Fahim Abbasi, James W Chu, et al.
Human Reproduction (Oxford, England)|September 13, 2005
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndromeNicholas A Cataldo, Fahim Abbasi, Tracey L McLaughlin, et al.
Diabetes Care|June 26, 2014
Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled studySun H Kim, Alice Liu, Danit Ariel, et al.
Journal of Clinical Lipidology|September 10, 2015
Salsalate-induced changes in lipid, lipoprotein, and apoprotein concentrations in overweight or obese, insulin-resistant, nondiabetic individualsDanit Ariel, Sun H Kim, Alice Liu, et al.
Obesity Surgery|June 27, 2009
Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopeniaSun H Kim, Teresa C Liu, Fahim Abbasi, et al.
Diabetes|July 28, 2005
Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individualsSun H Kim, Fahim Abbasi, James W Chu, et al.
Stem Cell Research & Therapy|July 31, 2019
The role of insulin as a key regulator of seeding, proliferation, and mRNA transcription of human pluripotent stem cellsMohammad Shahbazi, Paige Cundiff, Wenyu Zhou, et al.
Metabolism: Clinical and Experimental|November 16, 2012
Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clampJoshua W Knowles, Themistocles L Assimes, Philip S Tsao, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 7, 2003
Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitorsGeorge Beatty, Mandana Khalili, Fahim Abbasi, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|December 15, 2005
Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexesFahim Abbasi, Sang-Ah Chang, James W Chu, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
The American Journal of Cardiology|January 12, 2005
Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemiaCindy Lamendola, Fahim Abbasi, James W Chu, et al.
Human Reproduction (Oxford, England)|September 13, 2005
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndromeNicholas A Cataldo, Fahim Abbasi, Tracey L McLaughlin, et al.
Diabetes Care|June 26, 2014
Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled studySun H Kim, Alice Liu, Danit Ariel, et al.
Journal of Clinical Lipidology|September 10, 2015
Salsalate-induced changes in lipid, lipoprotein, and apoprotein concentrations in overweight or obese, insulin-resistant, nondiabetic individualsDanit Ariel, Sun H Kim, Alice Liu, et al.
Obesity Surgery|June 27, 2009
Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopeniaSun H Kim, Teresa C Liu, Fahim Abbasi, et al.
Diabetes|July 28, 2005
Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individualsSun H Kim, Fahim Abbasi, James W Chu, et al.
Stem Cell Research & Therapy|July 31, 2019
The role of insulin as a key regulator of seeding, proliferation, and mRNA transcription of human pluripotent stem cellsMohammad Shahbazi, Paige Cundiff, Wenyu Zhou, et al.
Metabolism: Clinical and Experimental|November 16, 2012
Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clampJoshua W Knowles, Themistocles L Assimes, Philip S Tsao, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 7, 2003
Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitorsGeorge Beatty, Mandana Khalili, Fahim Abbasi, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|December 15, 2005
Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexesFahim Abbasi, Sang-Ah Chang, James W Chu, et al.
Pageof 12